Neuro research
Cerebrolysin
The VaultLabs Cerebrolysin 60mg line is a lyophilized research preparation catalogued under that name at a nominal 60 mg fill. It is a mixture, so no single CAS number, formula or sequence is assigned. It is not a record of the licensed injectable solution sold under the Cerebrolysin trademark, and it is not an approved medicine from VaultLabs.
Research use only. For in vitro research use only. Not for human or animal consumption. Not for human consumption, medical use, or personal application.
Reviewed by VaultLabs Research Editorial Desk · Last updated 2026-10-20
Key facts
- Nominal fill is 60 mg of lyophilized material.
- No single CAS number. A mixture does not have one registry number.
- Not a single-sequence peptide and not interchangeable with Semax or Pinealon.
- Not the licensed porcine-brain injectable described in clinical papers.
- Identity for a received unit is the lot record.
- Supplied for laboratory research. Not for human use.
- Catalogue name
- Cerebrolysin 60mg research preparation
- Composition
- Mixture — no single sequence is assigned
- CAS number
- Not applicable — mixture
- Catalog strength
- 60 mg nominal fill
- Distinct from
- Licensed injectable sold under the same trademark
What Cerebrolysin is
Clinical papers that use the word Cerebrolysin are about a licensed porcine-brain preparation supplied as a solution by its manufacturer. This catalogue line is a 60 mg lyophilized research material under the same name. Those are not the same article of commerce. VaultLabs does not claim the licensed composition, does not invent a peptide list, and does not print a CAS number that would pretend the mixture is one substance.
The VaultLabs Cerebrolysin 60mg line is a lyophilized research preparation catalogued under that name at a nominal 60 mg fill. It is a mixture, so no single CAS number, formula or sequence is assigned. It is not a record of the licensed injectable solution sold under the Cerebrolysin trademark, and it is not an approved medicine from VaultLabs.
How VaultLabs catalogues it
One fill: Cerebrolysin 60mg. The monograph is /compounds/cerebrolysin. Do not file a Semax or Pinealon certificate against it. Papers linked from the monograph discuss the licensed preparation. The citation notes say that.
A purchase order should say Cerebrolysin 60mg lyophilized research preparation, not simply the trademark. Receiving matches the lot. If no public report is posted, the report is available on request.
Lots and receiving
Each sealed unit carries its own lot number. The current catalogue certificate for that lot is published on the batch page and states purity of at least 99.8 percent on the same VaultLabs template used for the rest of the lyophilized catalogue. A certificate for one fill does not qualify another fill. A certificate for a blend does not qualify a single-sequence vial that happens to share part of a name. Do not copy a purity figure from a different product, from a photograph of another vial, or from a paper into the receiving file. Match the printed name, the nominal mass and the lot number on the vial to the published record. If those three do not agree, hold the unit and ask for the document that belongs to that unit before it leaves quarantine. Enter the printed lot at batch verification.
Storage and research-use boundary
Keep the sealed lyophilized vial at 2 to 8 degrees Celsius, protected from light and from moisture, until it is opened under the laboratory's own procedure. Allow the closed vial to reach room temperature before the seal is broken, so water from humid coastal air does not condense on the dry cake. Bacteriostatic water and sterile water are separate catalogue lines. They are not packed inside the peptide box, because the receiving laboratory chooses the medium in its own procedure. VaultLabs does not publish a preparation method on this page. After the seal is opened, solution age, container and freeze cycles are controlled by the laboratory, not by the catalogue page.
The material is supplied for in vitro laboratory research only. It is not for human or animal consumption. It is not an approved medicine, not a finished cosmetic, and not a personal-use item. Papers cited on the compound monograph describe other people's experiments. Those papers are not a description of what this vial will do, and they are not instructions for any person or animal. A buyer who needs a registered medicine should use a licensed pharmacy channel. This page exists so a procurement officer in the UAE can identify the catalogue line, the fill, the price band and the paperwork before raising an order.
Research interest areas
Nominal fill is 60 mg of lyophilized material.
No single CAS number. A mixture does not have one registry number.
Not a single-sequence peptide and not interchangeable with Semax or Pinealon.
Not the licensed porcine-brain injectable described in clinical papers.
Storage information
2–8 °C (lyophilized, sealed)
2–8 °C sealed lyophilized storage, protected from light and humidity.
Stability notes
Keep the sealed lyophilized vial at 2 to 8 degrees Celsius, protected from light and from moisture, until it is opened under the laboratory's own procedure. Allow the closed vial to reach room temperature before the seal is broken, so water from humid coastal air does not condense on the dry cake. Bacteriostatic water and sterile water are separate catalogue lines. They are not packed inside the peptide box, because the receiving laboratory chooses the medium in its own procedure. VaultLabs does not publish a preparation method on this page. After the seal is opened, solution age, container and freeze cycles are controlled by the laboratory, not by the catalogue page.
Selected literature
Named papers behind the statements on this page. Each entry resolves on PubMed and through its DOI, so you can read the source rather than take our summary of it. Inclusion describes the research record and is not a claim about this material’s suitability for any use.
Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis.
Jarosz K, et al. · Brain Sciences · 2023
This review is about the licensed preparation in patients. It is not a result for the VaultLabs 60 mg lyophilized line and is not a use instruction.
Cerebrolysin in Patients with Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis.
Kojder K, et al. · Journal of Clinical Medicine · 2023
Also about the licensed preparation. Cited so the catalogue line is not confused with that product.
Databases and verification
Registry and database entries for independent identity checks. These are standing searches rather than fixed records, so they stay current as new work is indexed.
- Cerebrolysin on PubChem — PubChem
- Cerebrolysin literature search — PubMed
- PubMed record for the first cited paper — PubMed